id
stringlengths
1
5
question_id
stringlengths
1
5
document_id
stringlengths
5
7
question
stringlengths
55
970
type
stringclasses
1 value
choices
list
context
stringlengths
0
971
answer
sequence
9500
13140
3525331
Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on proportion of patients with a reduction of migraine days by at least 50%?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033)
[ "significantly decreased" ]
9501
13141
3525331
Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on frequency of migraine attacks?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033)
[ "significantly decreased" ]
9502
13142
3525331
Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on attack frequency?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033)
[ "significantly decreased" ]
9503
13143
3525331
Compared to placebo what was the result of Chinese herbal ChuanXiong Ding Tong herbal formula granule (CXDT-HFG) on The number of patients using acute pain drugs, such as aspirin, phenacetin, or ibuprofen, etc.?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
In other words, the mean reduction of migraine days in the CXDT-HFG group were 3.04 days, compared with 2.20 days in the placebo group at 12 weeks (95% CI, −4.13 to −1.93 versus 95% CI, −3.74 to −0.66; P = 0.033)
[ "no significant difference" ]
9504
13144
3672764
Compared to SC placebo at baseline plus oral indomethacin as above what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; on change in pain in the index joint?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed.
[ "no significant difference" ]
9505
13145
3672764
Compared to SC placebo at baseline plus oral indomethacin as above what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days; on Pain reduction?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed.
[ "no significant difference" ]
9506
13146
3672764
Compared to SC placebo at baseline plus oral indomethacin as above what was the result of SC rilonacept 320 mg at baseline plus oral placebo on Pain reduction according to the numerical rating scale (NRS)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed.
[ "significantly increased" ]
9507
13147
3672764
Compared to SC rilonacept 320 mg at baseline plus oral placebo what was the result of subcutaneous (SC) rilonacept 320 mg at baseline plus oral indomethacin 50 mg TID for 3 days followed by 25 mg TID for up to 9 days on high sensitivity C-reactive protein (hs-CRP)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although primary endpoint pain reduction was greater with rilonacept plus indomethacin (-1.55 ± 0.92) relative to indomethacin alone (-1.40 ± 0.96), the difference was not statistically significant (P = 0.33), so formal comparison between monotherapy groups was not performed.
[ "significantly increased" ]
9508
13148
4372550
Compared to lightwand with WEI JET under direct laryngoscopy what was the result of lightwand only; lightwand under direct laryngoscopy; on the intubation time?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
. Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000
[ "significantly decreased" ]
9509
13149
4372550
Compared to lightwand with WEI JET under direct laryngoscopy what was the result of lightwand only; on successful tracheal intubation attempts?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
. Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000
[ "significantly increased" ]
9510
13150
4372550
Compared to lightwand under direct laryngoscopy; what was the result of lightwand only; on successful tracheal intubation attempts?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
. Although the intubation time was significantly longer in the WEI group (110.8±18.3 s) than the LW group (63.3±27.5 s, p = 0.000) or DL group (66.7±29.4 s, p = 0.000
[ "no significant difference" ]
9511
13151
4188038
Compared to placebo what was the result of alpha-linolenic acid (ALA), a medium-chained, plant-based omega-3 fatty acid (18:3) on ADHD symptoms and a computerized continuous performance functions test. ?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
No between-group difference was found in the changes of the various measures of ADHD symptoms throughout the study period
[ "no significant difference" ]
9512
13156
4301466
Compared to Placebo group (placebo and mesalazine) what was the result of Diosmectite group (diosmectite and mesalazine) on clinical responses?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no significant difference in clinical responses between the Diosmectite group and the Placebo group (P>0.05).
[ "no significant difference" ]
9513
13157
4301466
Compared to Placebo group (placebo and mesalazine) what was the result of Diosmectite group (diosmectite and mesalazine) on The defecation frequency?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no significant difference in clinical responses between the Diosmectite group and the Placebo group (P>0.05).
[ "no significant difference" ]
9514
13158
5951872
Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on experienced symptoms, concerns about the illness?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02).
[ "significantly increased" ]
9515
13159
5951872
Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on emotional impact of the disease?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02).
[ "no significant difference" ]
9516
13160
5951872
Compared to ‘usual care.’ what was the result of survivorship care plans (SCPs) on trust that the treatment would help to cure the illness?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Significantly more endometrial patients in the SCP care arm compared to the usual care arm reported high experienced symptoms (18% vs 9%, p = 0.02) and high concerns about the illness (16% vs 7%, p = 0.02).
[ "no significant difference" ]
9517
13161
5799990
Compared to Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used what was the result of Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer on periapical healing evaluated by Kruskal–Wallis test?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
When scores obtained by radiographic evaluation were submitted to Kruskal–Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluation with P = 0.342, 0.839, 0.218, and 0.780, respectively
[ "no significant difference" ]
9518
13162
5799990
Compared to Group II was obturated at the first visit. subgroup IB and subgroup IIB, AH Plus sealer was used what was the result of Group I was medicated with ApexCal paste and obturated using the standardized protocol in second visit 7–10 days later. subgroup IA and subgroup IIA, obturation was done using Apexit Plus sealer on periapical healing evaluated by one-way ANOVA test?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
When scores obtained by radiographic evaluation were submitted to Kruskal–Wallis test, there was no statistically significant difference in periapical healing between teeth in subgroups IA, IB, IIA, and IIB at the baseline, 1-, 3-, or 6-month evaluation with P = 0.342, 0.839, 0.218, and 0.780, respectively
[ "no significant difference" ]
9519
13167
5980435
Compared to noncross‐matched blood type compatible pRBCs what was the result of received cross‐match and blood type compatible pRBCs on incidence of transfusion reactions?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
No significant difference in incidence of transfusion reactions between cross‐matched and noncross‐matched groups (CM+ 4/24; 17%, CM– 7/24; 29%, P = .16).
[ "no significant difference" ]
9520
13168
5980435
Compared to noncross‐matched blood type compatible pRBCs what was the result of received cross‐match and blood type compatible pRBCs on packed cell volume?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
No significant difference in incidence of transfusion reactions between cross‐matched and noncross‐matched groups (CM+ 4/24; 17%, CM– 7/24; 29%, P = .16).
[ "no significant difference" ]
9521
13169
5827295
Compared to split part-time occlusion what was the result of continuous occlusion on visual acuity’s improvement?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Best corrected visual acuity’s improvement was comparable between continuous and split part-time occlusion (0.20±0.27 vs 0.21±0.25; p = 0.79).
[ "no significant difference" ]
9522
13171
5986584
Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on weight loss?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group
[ "significantly increased" ]
9523
13172
5986584
Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on total fat mass?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group
[ "significantly decreased" ]
9524
13173
5986584
Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on apoptotic or proliferation index?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group
[ "no significant difference" ]
9525
13174
5986584
Compared to control group what was the result of WL program consisting of standard structured energy-restricted meal plans (1200–1500 Kcal/day) and physical activity on triglyceride and insulin level?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Subjects in the intervention group had significantly more weight loss (WL:−3.7 ± 0.5 kg; Control:−1.6 ± 0.5 kg; p=0.007) than the control group
[ "significantly decreased" ]
9526
13175
5773985
Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on mean volume of both the solutions used?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).
[ "no significant difference" ]
9527
13176
5773985
Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on subjective and objective onset of action?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).
[ "no significant difference" ]
9528
13177
5773985
Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on duration of surgical procedure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).
[ "no significant difference" ]
9529
13178
5773985
Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on the mean duration of postoperative analgesia?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).
[ "significantly decreased" ]
9530
13179
5773985
Compared to mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 μg buprenorphine (3 μg/kg)in group II what was the result of 0.5% bupivacaine with 1:200000 epinephrine in group I on number of analgesic tablets?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference in the mean volume of both the solutions used was found to be statistically nonsignificant (P = 0.84).
[ "significantly increased" ]
9531
13180
1190172
Compared to covering letter a hand written signature what was the result of covering letter with either a computer printed signature on time to response?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Kaplan-Meier survival analysis was performed on time to response and no difference between the groups was detected (Log rank = 0.72, p = 0.39; Figure 2).
[ "no significant difference" ]
9532
13181
5771543
Compared to placebo what was the result of fluoxetine on CGI-I response rate?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017).
[ "significantly increased" ]
9533
13182
5771543
Compared to placebo what was the result of desvenlafaxine on CGI-I response rate?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017).
[ "no significant difference" ]
9534
13183
5771543
Compared to placebo what was the result of desvenlafaxine, fluoxetine on Treatment-emergent adverse events (TEAEs)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At week 8, the CGI-I response rate for fluoxetine (78.2%) was significantly greater compared with placebo (62.6%; p = 0.017).
[ "no significant difference" ]
9535
13184
3269419
Compared to SP+(3 d)AS what was the result of CQ+(3 d)AS; on gametocytaemia?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
By contrast, artesunate seemed as effective when combined with chloroquine as it was when combined with SP (MH-OR = 1.04, P = 0.83).
[ "significantly decreased" ]
9536
13185
5722980
Compared to mobile app designed to help with symptoms of anxiety in general (called Stress Free). what was the result of mobile app designed to target agoraphobia (called Agoraphobia Free) on symptom severity over time?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Both groups had statistically significant improvements in symptom severity over time (difference –5.97, 95% CI –8.49 to –3.44, P<.001 for Agoraphobia Free and –6.35, 95% CI –8.82 to –3.87, P<.001 for Stress Free), but there were no significant between-group differences on the primary outcome (difference 0.38, 95% CI –1.96 to 3.20, P=.64).
[ "no significant difference" ]
9537
13186
5722980
Compared to mobile app designed to help with symptoms of anxiety in general (called Stress Free). what was the result of mobile app designed to target agoraphobia (called Agoraphobia Free) on PAS: Panic and Agoraphobia Scale?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Both groups had statistically significant improvements in symptom severity over time (difference –5.97, 95% CI –8.49 to –3.44, P<.001 for Agoraphobia Free and –6.35, 95% CI –8.82 to –3.87, P<.001 for Stress Free), but there were no significant between-group differences on the primary outcome (difference 0.38, 95% CI –1.96 to 3.20, P=.64).
[ "no significant difference" ]
9538
13187
3544627
Compared to fast eating what was the result of slow eating on hunger at 5, 10, 15, 20 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly increased" ]
9539
13188
3544627
Compared to fast eating what was the result of slow eating on hunger at 60 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly decreased" ]
9540
13189
3544627
Compared to fast eating what was the result of slow eating on desire-to-eat at 5, 10, 15, 20 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly increased" ]
9541
13190
3544627
Compared to fast eating what was the result of slow eating on desire-to-eat at 60 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly decreased" ]
9542
13191
3544627
Compared to slow eating what was the result of fast eating on satiety at 5, 10, 15, 20 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly increased" ]
9543
13192
3544627
Compared to slow eating what was the result of fast eating on satiety at 60 min?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Post hoc testing revealed that in the slow condition, hunger was significantly higher at 5, 10, 15, and 20min (p < 0.001) and was significantly lower at 60min (p = 0.003) compared with the fast condition, as shown in Figure 2A.
[ "significantly decreased" ]
9544
13193
3646783
Compared to placebo what was the result of 30-months inhaled steroids treatment on percentage stained area of versican and collagen III?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
30-Months inhaled steroids increased the percentage stained area of versican (9.6% [CI 0.9 to 18.3%]; p = 0.03) and collagen III (20.6% [CI 3.8 to 37.4%]; p = 0.02) compared to placebo.
[ "significantly increased" ]
9545
13194
4702321
Compared to placebo what was the result of ivacaftor (150&nbsp;mg) on Respiratory Symptoms scale?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Respiratory Symptoms scale with a mean improvement of 5.9 points observed among patients receiving ivacaftor, exceeding the MCID value of 4 points, vs. a mean decline of 2.7 points among those receiving placebo (treatment effect of 8.6 points, P < 0.001) [12].Table 1
[ "significantly increased" ]
9546
13195
4702321
Compared to placebo what was the result of ivacaftor (150 mg) on Physical Functioning , Health Perceptions, and Vitality?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Respiratory Symptoms scale with a mean improvement of 5.9 points observed among patients receiving ivacaftor, exceeding the MCID value of 4 points, vs. a mean decline of 2.7 points among those receiving placebo (treatment effect of 8.6 points, P < 0.001) [12].Table 1
[ "significantly increased" ]
9547
13196
5747107
Compared to (iii) treatment as usual only what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on Hamilton Depression Rating Scale?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis).
[ "no significant difference" ]
9548
13197
5747107
Compared to (iii) treatment as usual only what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on symptomatic remission?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis).
[ "no significant difference" ]
9549
13198
5747107
Compared to (ii) six weeks of ESM without feedback, what was the result of ESM-I consisting of six weeks of ESM combined with weekly feedback regarding the individual’s positive affective experiences on rate of symptomatic remission?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At 32 weeks, mean HDRS score was three units lower in the ESM-I group than in the control group (after adjustment for baseline HDRS scores), which was statistically imprecise by conventional alpha (Table 3; B = −3.1, p = 0.051, intention-to-treat analysis).
[ "no significant difference" ]
9550
13199
3616744
Compared to placebo what was the result of atomoxetine on relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At the 9-month study endpoint, 22.3% of subjects who continued with atomoxetine exhibited relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale) compared to 37.9% of those given a placebo (P = 0.002)
[ "significantly decreased" ]
9551
13200
3616744
Compared to placebo what was the result of lisdexamfetamine dimesylate (LDX) on symptom relapse?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
At the 9-month study endpoint, 22.3% of subjects who continued with atomoxetine exhibited relapse (defined as symptom return ≥ 90% of baseline in ADHD Rating Scale (ADHD-RS) total scores and ≥ 2 points on the CGI-Severity [CGI-S] scale) compared to 37.9% of those given a placebo (P = 0.002)
[ "significantly decreased" ]
9552
13201
5986495
Compared to water (WAT), NNS-sweetened (NNS) what was the result of a sucrose-sweetened (SUC) drink on Plasma glucose and insulin concentrations?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively.
[ "significantly increased" ]
9553
13202
5986495
Compared to water (WAT), what was the result of a sucrose-sweetened (SUC) drink on Plasma ghrelin concentration?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively.
[ "significantly decreased" ]
9554
13203
5986495
Compared to water (WAT), what was the result of NNS-sweetened (NNS) on Plasma ghrelin concentration?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively.
[ "no significant difference" ]
9555
13204
5986495
Compared to water (WAT), NNS-sweetened (NNS) what was the result of a sucrose-sweetened (SUC) drink on Hunger ratings?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively.
[ "significantly decreased" ]
9556
13205
5986495
Compared to water (WAT) what was the result of NNS-sweetened (NNS) on Hunger ratings?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Plasma glucose and insulin concentrations were significantly higher in SUC at T = 30 min (glucose: t17 = −3.77 and t17= −2.46; insulin: t17 = −3.94 and t17 = −5.11; all p < 0.05) as compared to WAT and NNS, respectively.
[ "no significant difference" ]
9557
13206
4745960
Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on The mean of visual capacity?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049.
[ "significantly increased" ]
9558
13207
4745960
Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Intraocular pressure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049.
[ "no significant difference" ]
9559
13208
4745960
Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Surgical success?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049.
[ "no significant difference" ]
9560
13209
4745960
Compared to standard trabeculectomy (TBC) what was the result of EX-PRESS P-50 implant on Surgical complications?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The mean of visual capacity measured in logarithm of the minimum angle of resolution (logMAR), per group of treatment during the study period (1 day, 1 week, 1 month, 3, 6, and 12 months), showed on the first day a significant difference in visual acuity between the EX-PRESS P-50 and TBC groups, with P=0.049.
[ "no significant difference" ]
9561
13210
4681154
Compared to group S - SNB with 20&nbsp;ml of 0.375&nbsp;% ropivacaine what was the result of group L - 100-ml injections of 0.2&nbsp;% ropivacaine and 0.5&nbsp;mg epinephrine to the surgical region on Numeric Rating Scale (NRS) score?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
NRS score changes were greater in group L than in group S (P < 0.01, ANOVA) and greater in group L than in group S at three postoperative time points: 3 h (P < 0.01), 6 h (P < 0.01), and 12 h (P = 0.013; Mann–Whitney U test).
[ "significantly increased" ]
9562
13211
4681154
Compared to group S - SNB with 20ml of 0.375% ropivacaine what was the result of group L - 100-ml injections of 0.2 ropivacaine and 0.5mg epinephrine to the surgical region on side effects?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
NRS score changes were greater in group L than in group S (P < 0.01, ANOVA) and greater in group L than in group S at three postoperative time points: 3 h (P < 0.01), 6 h (P < 0.01), and 12 h (P = 0.013; Mann–Whitney U test).
[ "no significant difference" ]
9563
13212
4511442
Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial.
[ "no significant difference" ]
9564
13213
4511442
Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on pressure support ventilation (PSV) and positive end-expiratory pressure (PEEP)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial.
[ "significantly decreased" ]
9565
13214
4511442
Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on Total duration of mechanical ventilation and extubation failure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial.
[ "no significant difference" ]
9566
13215
4511442
Compared to respiratory physiotherapy–driven weaning what was the result of progressive discontinuation of pressure support ventilation (PSV) with SmartCare™ on Weaning duration?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no difference in maximal inspiratory pressure, maximal expiratory pressure, forced vital capacity or rapid shallow breathing index at the beginning of the weaning trial.
[ "significantly increased" ]
9567
13216
4458006
Compared to 2&nbsp;cm distally, at the main bifurcation (group 2) what was the result of facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1) on amplitude of whisking?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was no statistically significant difference between the two groups at 2, 4, and 6 weeks after facial nerve surgery (p > 0.05).
[ "no significant difference" ]
9568
13217
5816600
Compared to non-ARB therapy what was the result of angiotensin II receptor blocker (ARB)-based antihypertensive therapy on urinary albumin/creatinine ratio (UACR)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
UACR was significantly less in ARB group than in non-ARB group during follow-up period in patients with G3b and/or A3 (P = 0.0003),
[ "significantly decreased" ]
9569
13219
5816600
Compared to non-ARB therapy what was the result of angiotensin II receptor blocker (ARB)-based antihypertensive therapy on incidence of cardiovascular events?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
UACR was significantly less in ARB group than in non-ARB group during follow-up period in patients with G3b and/or A3 (P = 0.0003),
[ "significantly decreased" ]
9570
13222
4752899
Compared to placebo what was the result of praziquantel (60 mg/kg in split dose) on the percent change in S. japonicum (epg) from screening to 22 weeks gestation?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was also a difference between groups in the percent change in S. japonicum (epg) from screening to 22 weeks gestation, though this did not reach statistical significance (−53.11 versus 128.7; P = 0.054).
[ "no significant difference" ]
9571
13223
4752899
Compared to placebo what was the result of praziquantel (60 mg/kg in split dose) on creatinine?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
There was also a difference between groups in the percent change in S. japonicum (epg) from screening to 22 weeks gestation, though this did not reach statistical significance (−53.11 versus 128.7; P = 0.054).
[ "significantly increased" ]
9572
13224
5983010
Compared to control group what was the result of DHA supplementation group on Macular sensitivity?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Macular sensitivity increased from a mean (SD) of 25.9 (2.4) dB at baseline to 27.3 (2.3) dB at 90 days (P=0.030) in the DHA group only (between-group differences P<0.19).
[ "no significant difference" ]
9573
13225
5983010
Compared to control group what was the result of DHA supplementation group on The macular integrity index?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Macular sensitivity increased from a mean (SD) of 25.9 (2.4) dB at baseline to 27.3 (2.3) dB at 90 days (P=0.030) in the DHA group only (between-group differences P<0.19).
[ "significantly decreased" ]
9574
13226
5735450
Compared to air group what was the result of lignocaine group on Cuff pressure and volume achieved in the end of surgery?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Cuff pressure and volume achieved in the end of surgery were much higher in air group as compared to lignocaine group (P < 0.05).
[ "significantly decreased" ]
9575
13227
5735450
Compared to air group what was the result of lignocaine group on incidence of coughing?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Cuff pressure and volume achieved in the end of surgery were much higher in air group as compared to lignocaine group (P < 0.05).
[ "significantly decreased" ]
9576
13228
5791588
Compared to investigational TdaP (groups: T5d2aP1, T5d2aP2, T5d2aP4, T5d4aP1, T5d4aP2, T5d4aP4) what was the result of investigational aP (groups: aP1, aP2, and aP4), on pertussis toxin (PT)-specific PB?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although there were no major differences across the 3 vaccine groups in percentage of participants with measurable frequencies of IgG-secreting PB, there was a significantly higher frequency of PT-specific PB in the high aP dose Tdap group than in the low-dose group (p < 0.0015
[ "significantly increased" ]
9577
13229
5791588
Compared to T5d2aP1 group and T5d2aP4 what was the result of licensed TdaP comparator on IgG-secreting PB against filamentous hemagglutinin [FHA] antige?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Although there were no major differences across the 3 vaccine groups in percentage of participants with measurable frequencies of IgG-secreting PB, there was a significantly higher frequency of PT-specific PB in the high aP dose Tdap group than in the low-dose group (p < 0.0015
[ "significantly increased" ]
9578
13236
3540345
Compared to watched the video what was the result of written information as a refresher on able to apply the technique?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The difference observed between those who had seen the video and those who had read up on the technique turned out to be an average of 6.19 points in favour of the first (P < 0.05)
[ "significantly increased" ]
9579
13238
3611107
Compared to placebo what was the result of Lactobacillus gasseri BNR17 on total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
All serum lipids including total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride showed no significant clinical differences between the two groups.
[ "no significant difference" ]
9580
13239
3611107
Compared to placebo what was the result of Lactobacillus gasseri BNR17 on systolic or diastolic blood pressure, pulse rate?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
All serum lipids including total cholesterol, high density lipoprotein, low density lipoprotein (LDL), and triglyceride showed no significant clinical differences between the two groups.
[ "no significant difference" ]
9581
13240
5644405
Compared to filtration surgerie (tube) what was the result of filtration surgerie ( trabeculectomy) on The end-pressure difference (intraocular pressure at 60 minutes)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The end-pressure difference (intraocular pressure at 60 minutes vs. baseline) was significantly greater in the tube group (5.6 ± 3.6 mmHg; 41% change) than in the trabeculectomy group (3.2 ± 4.7; 23% change; P = 0.03)
[ "significantly decreased" ]
9582
13241
3686216
Compared to home access to traditional electronic games what was the result of no home access to electronic games, on moderate/vigorous physical activity (MVPA)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Table 1 shows that in comparison to traditional games, removal of all electronic games resulted in no significant change in daily MVPA over the whole week.
[ "no significant difference" ]
9583
13242
3686216
Compared to home access to traditional electronic games what was the result of active input games on sedentary time in the after-school period?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Table 1 shows that in comparison to traditional games, removal of all electronic games resulted in no significant change in daily MVPA over the whole week.
[ "significantly decreased" ]
9584
13243
4784348
Compared to standard intervention what was the result of invited to access the e-therapeutic platform (Next.Step) during 12&nbsp;weeks in addition to the standard intervention on perceived benefits?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Multiple comparisons showed that, in general, the mean score of perceived benefits at 3 months was lower (M = 4.52; SD = .07) than the mean score at 0 months (M = 4.48; SD = .06), but there was no significant differences.
[ "no significant difference" ]
9585
13245
4359698
Compared to the walking and running CPETs what was the result of cycling maximal cardiopulmonary exercise testing (CPET) on The root mean square of successive R-R differences calculated for consecutive 30-s windows (rMSSD30s), heart rate recovery (HRR)?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Both HRR and rMSSD30s were significantly greater during recovery from the cycling CPET compared to the walking and running CPETs (P < 0.001).
[ "significantly increased" ]
9586
13246
4359698
Compared to the walking and running CPETs what was the result of cycling maximal cardiopulmonary exercise testing (CPET) on VO2peak, HRpeak, peak oxygen pulse, and energy expenditure?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Both HRR and rMSSD30s were significantly greater during recovery from the cycling CPET compared to the walking and running CPETs (P < 0.001).
[ "significantly decreased" ]
9587
13247
5758845
Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on FAACT ACS?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245)
[ "no significant difference" ]
9588
13248
5758845
Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on anorexia VAS?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245)
[ "no significant difference" ]
9589
13249
5758845
Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on ACTH, cortisol, ghrelin, IL-6, ESR, and CRP?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245)
[ "no significant difference" ]
9590
13250
5758845
Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on qi deficiency scale and blood deficiency scale?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245)
[ "no significant difference" ]
9591
13251
5758845
Compared to placebo what was the result of 3 g of Sipjeondaebo-tang on systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse, AST, ALT, blood urea nitrogen (BUN), and creatinine?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
but the changes of FAACT ACS score were not significantly different between the two groups (p = 0.245)
[ "no significant difference" ]
9592
13252
29053
Compared to ventilated with a hydrophobic heat-moisture exchanger (HME) or a hygroscopic HME what was the result of ventilated with a heated humidifier (HH) on Total respiratory heat loss?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Total respiratory heat loss was significantly less with the HH than with either HME (P < 0.01)
[ "significantly decreased" ]
9593
13253
29053
Compared to ventilated with a hydrophobic heat-moisture exchanger (HME) or a hygroscopic HME what was the result of ventilated with a heated humidifier (HH) on inspired RH and AH over the 24-h ?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
Total respiratory heat loss was significantly less with the HH than with either HME (P < 0.01)
[ "significantly increased" ]
9594
13254
3598524
Compared to endotracheal intubation what was the result of Combitube, EasyTube, I-Gel, Laryngeal Mask Airway and Laryngeal tube on The median of overall hands-off time?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The median of overall hands-off time was significantly higher for endotracheal intubation (39.4s; 95% CI 34.0-44.9s) compared to Laryngeal tube (6.1s; 5.2-6.9s), Combitube (7.9s; 6.9-9.0s), LMA (10.2s; 8.6-11.7s), EasyTube (8.8s; 7.3-10.3s), and I-Gel (11.9s; 10.2-13.7s) (Table 1).
[ "significantly decreased" ]
9595
13255
3598524
Compared to endotracheal intubation what was the result of Combitube, EasyTube, I-Gel, Laryngeal Mask Airway and Laryngeal tube on Mean number of attempts?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The median of overall hands-off time was significantly higher for endotracheal intubation (39.4s; 95% CI 34.0-44.9s) compared to Laryngeal tube (6.1s; 5.2-6.9s), Combitube (7.9s; 6.9-9.0s), LMA (10.2s; 8.6-11.7s), EasyTube (8.8s; 7.3-10.3s), and I-Gel (11.9s; 10.2-13.7s) (Table 1).
[ "significantly decreased" ]
9596
13256
4527103
Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on reduction of cough severity?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2).
[ "no significant difference" ]
9597
13257
4527103
Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on adverse events?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2).
[ "significantly increased" ]
9598
13258
4527103
Compared to received homeopathic syrup alone for 10 days what was the result of received homeopathic syrup for 10 days plus oral antibiotic treatment (amoxicillin/clavulanate, clarithromycin, and erythromycin) for 7 days on cough resolution?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
with a non-significant difference in progressive reduction of cough severity between the two groups (Table 2).
[ "no significant difference" ]
9599
13259
3733617
Compared to receive no pen what was the result of receive an attractive pen on The final response rate?
multiple_choice
[ "significantly increased", "no significant difference", "significantly decreased" ]
The final response rate for the intervention and control group were 61.9% and 46.8% respectively and was not statistically significant (Chi-square = 2.89, P = 0.089).
[ "no significant difference" ]